The proposed therapeutic schema effectively inhibited the growth of subcutaneous grafts in both selected groups, and such a positive trend was observed both in mice receiving CP only and in those receiving a combined CP + DNAmix therapy ( Figure 4C ).
← all excerpts
Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma.
1
—
—